10 studies found for:    Open Studies | Hypertension | UCSD OR UC San Diego OR VA San Diego
Show Display Options
Rank Status Study
1 Recruiting Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Condition: Portopulmonary Hypertension
Intervention: Drug: Ambrisentan
2 Recruiting PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial
Condition: Portopulmonary Hypertension
Interventions: Drug: Macitentan;   Other: Placebo
3 Recruiting U.S. CTEPH Registry
Conditions: Chronic Thromboembolic Pulmonary Hypertension (CTEPH);   Pulmonary Hypertension
Intervention:
4 Recruiting New International CTEPH Database
Conditions: Chronic Thromboembolic Pulmonary Hypertension;   CTEPH
Intervention:
5 Recruiting Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: Bimatoprost sustained-release;   Other: Sham;   Drug: Timolol;   Drug: Timolol Vehicle (placebo)
6 Recruiting Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan 10 mg;   Drug: Placebo
7 Unknown  24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
Condition: Glaucoma
Intervention: Device: SLT (selective laser trabeculoplasty ) SENSIMED Triggerfish
8 Unknown  24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
Condition: Glaucoma
Intervention: Device: Phacoemulsification with implantation of intraocular lens (CE-IOL) SENSIMED Triggerfish
9 Recruiting Diagnostic Innovations in Glaucoma Study
Condition: Primary Open Angle Glaucoma
Intervention:
10 Unknown  STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk (STARFISH)
Condition: Primary Open Angle Glaucoma
Intervention:

Indicates status has not been verified in more than two years